ID   ZYXY-M1
AC   CVCL_B6YP
DR   CCRID; 4201PAT-CCTCC01831
DR   Wikidata; Q112041949
RX   Patent=CN113046319B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC 202144.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Patent=CN113046319B
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 21,22
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 12,19
ST   D19S433: 13,15.2
ST   D1S1656: 15,16
ST   D21S11: 30,32
ST   D2S1338: 19,23
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D6S1043: 14,18
ST   D7S820: 10,11
ST   D8S1179: 10,11
ST   FGA: 22,23
ST   Penta D: 10,13
ST   Penta E: 12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
RX   Patent=CN113046319B;
RA   Jin J., Li F.-L., Wang H.-F.;
RT   "Human acute myeloid leukemia cell line and application thereof.";
RL   Patent number CN113046319B, 08-Nov-2022.
//